Related Experiment Video
Updated: Jun 20, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
Recombinant vectors as influenza vaccines
Sarah A Kopecky-Bromberg1, Peter Palese
1Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
Abstract:
The antiquated system used to manufacture the currently licensed inactivated influenza virus vaccines would not be adequate during an influenza virus pandemic. There is currently a search for vaccines that can be developed faster and provide superior, long-lasting immunity to influenza virus as well as other highly pathogenic viruses and bacteria. Recombinant vectors provide a safe and effective method to elicit a strong immune response to a foreign protein or epitope. This review explores the advantages and limitations of several different vectors that are currently being tested, and highlights some of the newer viruses being used as recombinant vectors.
Related Concept Videos
Viral Recombination
Recombinant DNA
Influenza
Leaky Scanning

